Form 4: Columbia Financial EVP Walden Acquires Shares Through Stock-Based Deferral Plan
SEC Form 4
EVP & CHRO of Columbia Financial, Jenifer White Walden, reports acquisition of common stock through a stock-based deferral plan and vesting of stock options.
Summary
- On May 31, 2024, Jenifer White Walden, EVP & CHRO of Columbia Financial, Inc. acquired common stock through the Columbia Bank Stock Based Deferral Plan at a price of $14.50 per share.
- The acquisition involved 36.7373 shares.
- Walden also holds stock options with exercise prices of $20.54, $15.94, and $16.49, which vest in installments on various dates.
- Walden indirectly owns shares through an ESOP, SERP, SIM, and various stock award plans.
- The stock awards vest over time, some based on performance criteria.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating standard executive compensation practices. There's no indication of significant positive or negative events.
Positives
- The acquisition of shares by an executive could be seen as a positive signal, indicating confidence in the company's future performance.
Future Outlook
The document does not contain explicit forward-looking statements, but the vesting schedules of stock awards and options suggest continued employment and potential future stock ownership.
Industry Context
This filing is typical for executives in publicly traded companies and reflects standard equity compensation practices.
Comparison to Industry Standards
- Equity compensation is a common practice among publicly traded companies to align the interests of executives with those of shareholders.
- Vesting schedules and performance-based awards are standard features of equity incentive plans, similar to those offered by peers like OceanFirst Financial Corp. and Investors Bancorp, Inc.
- The specific terms of the stock options and awards, such as vesting periods and exercise prices, are generally in line with industry norms for financial institutions of similar size and scope.
Stakeholder Impact
- The transaction has a minor positive impact on shareholders as it aligns executive interests with company performance.
Key Dates
| Date | Description |
|---|---|
| 10/31/2023 | Commencement of vesting for stock options with an exercise price of $20.54. |
| 05/01/2024 | Commencement of vesting for stock options with an exercise price of $15.94 and stock awards. |
| 05/31/2024 | Date of transaction: Acquisition of common stock through the Columbia Bank Stock Based Deferral Plan. |
| 03/06/2025 | Commencement of vesting for stock options with an exercise price of $16.49 and stock awards. |
| 10/31/2032 | Expiration date for stock options with an exercise price of $20.54. |
| 05/01/2033 | Expiration date for stock options with an exercise price of $15.94. |
| 03/06/2034 | Expiration date for stock options with an exercise price of $16.49. |
| 06/04/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.